MTOR and renal cell carcinoma: Though molecular analysis was not the object of the experimental investigation, representing a limitation of this work, the RCC-FMS genetic pattern would be defined by TSC-mTOR and ELOC/TCEB1 mutations with VHL wild-type without 3p deletion [13].